Atomwise

Atomwise is a preclinical pharma company revolutionizing how drugs are discovered using an Artificial intelligence (AI) engine.

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

Search Tags

AI drug discovery, machine learning pharmaceuticals, convolutional neural networks medicine

About Us

Atomwise is a biotechnology company that leverages artificial intelligence to accelerate drug discovery, focusing on developing small-molecule therapies. Using convolutional neural networks and vast chemical libraries, Atomwise’s technology identifies promising drug candidates with high precision. 

Trending Companies in AI

Latest Articles in AI

Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >
Anycubic Photon Mono M7 Pro for $469 with code AC30OFF. FREE $99 Gifts: 1*High Speed Resin+2*FEP Film+3000pcs Limited Mystery Box

CREATORS. DISRUPTORS. INNOVATORS.

Discover Emerging Technology Companies